London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024 11-06-2024, 01:33

ResMed Chief Administrative Officer and Global General Counsel to Retire 31-03-2023, 03:05

Amlan International and VetPro Forge Strategic Distributor Alliance to Drive Innovation in Animal Health Across Northern Brazil 25-10-2024, 03:00